Helix Biopharma Corp. Announces Fiscal Third Quarter 2020 Results
July 30, 2020 17:42 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, July 30, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer,...
Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results
July 13, 2020 07:30 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, July 13, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. to divest remaining ownership of Polish subsidiary
June 26, 2020 07:30 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, June 26, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the...
Helix BioPharma Corp. to Present at Proactive One2One Virtual Investor Forum
June 22, 2020 07:30 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, June 22, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results
June 11, 2020 17:15 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, June 11, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. L-DOS47 Phase I Lung Cancer Trial Data to be released at ASCO 2020
May 14, 2020 07:30 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, May 14, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Provides Corporate Update
April 02, 2020 07:30 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, April 02, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
HELIX BIOPHARMA CORP. ANNOUNCES FISCAL SECOND QUARTER 2020 RESULTS
March 16, 2020 19:51 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, March 16, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer,...
Helix BioPharma Corp. Closes $6.0 Million Private Placement
March 12, 2020 17:05 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, March 12, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. to Present at the Noble Capital Markets’ Sixteenth Annual Investor Conference
February 14, 2020 07:30 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...